Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)
type: MedicalStudy
description: Tegoprazan-Amoxicillin Dual Therapy Versus Esomeprazole-Based Bismuth Quadruple Therapy for First-Line Helicobacter Pylori Eradication: A Prospective, Randomized, Multicenter, Superiority Study (TATH-1)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2023-11-01
end date: 2025-10-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05647278
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Zhang Xiaofeng,MD
study subject: Helicobacter Pylori Infection
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Helicobacter Pylori Infection

AI Analytics
type: Organization